WoundSource Section Logos - White Papers

Non-Healing Contaminated Wounds: A Multidimensional Solution

Non-Healing Contaminated Wounds - A Multidimensional Solution
 

The care of chronic wounds has become increasingly complex, given the rise of drug-resistant organisms and the presence of multiple comorbid conditions in these patients. The costs of managing these wounds are high, and treatment—even using advanced wound care techniques—is often ineffective.

This useful guide, sponsored by the makers of DermaWound Original©, first discusses wound care modalities currently used in patients with non-healing chronic wounds. The guide then introduces DermaWound Original©, a transformative povidone-iodine–based solution that disrupts the biofilm and is cytotoxic to pathogenic microorganisms. Real-world case reports illustrate the efficacy of this new product in promoting wound healing.

Based on the early evidence of DermaWound Original© efficacy, wound care providers will welcome this promising new option for the treatment of non-healing chronic wounds.

This white paper covers the following topics:

Trends in chronic wound care
Financial burden of chronic wounds
Current treatments for chronic wounds
Efficacy of conventional treatments in wound healing
Mechanisms of action of DermaWound Original©
Efficacy of DermaWound Original©

This paper is written for wound care clinicians and purchasing directors with an interest in product solutions.

Sponsored by DermaWound®

The care of chronic wounds has become increasingly complex, given the rise of drug-resistant organisms and the presence of multiple comorbid conditions in these patients. The costs of managing these wounds are high, and treatment—even using advanced wound care techniques—is often ineffective.

This useful guide, sponsored by the makers of DermaWound Original©, first discusses wound care modalities currently used in patients with non-healing chronic wounds. The guide then introduces DermaWound Original©, a transformative povidone-iodine–based solution that disrupts the biofilm and is cytotoxic to pathogenic microorganisms. Real-world case reports illustrate the efficacy of this new product in promoting wound healing.

Based on the early evidence of DermaWound Original© efficacy, wound care providers will welcome this promising new option for the treatment of non-healing chronic wounds.

This white paper covers the following topics:

Trends in chronic wound care
Financial burden of chronic wounds
Current treatments for chronic wounds
Efficacy of conventional treatments in wound healing
Mechanisms of action of DermaWound Original©
Efficacy of DermaWound Original©

This paper is written for wound care clinicians and purchasing directors with an interest in product solutions.

Sponsored by DermaWound®

WoundSource
The World’s Definitive Source for Wound Care & Product Information